Page last updated: 2024-09-04

zosuquidar trihydrochloride and norfluoxetine

zosuquidar trihydrochloride has been researched along with norfluoxetine in 1 studies

Compound Research Comparison

Studies
(zosuquidar trihydrochloride)
Trials
(zosuquidar trihydrochloride)
Recent Studies (post-2010)
(zosuquidar trihydrochloride)
Studies
(norfluoxetine)
Trials
(norfluoxetine)
Recent Studies (post-2010) (norfluoxetine)
6012753369

Protein Interaction Comparison

ProteinTaxonomyzosuquidar trihydrochloride (IC50)norfluoxetine (IC50)
Potassium channel subfamily K member 2Homo sapiens (human)9
Sodium channel protein type 1 subunit alphaRattus norvegicus (Norway rat)0.8
Potassium voltage-gated channel subfamily C member 1Rattus norvegicus (Norway rat)0.8
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)2.2909

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J1

Other Studies

1 other study(ies) available for zosuquidar trihydrochloride and norfluoxetine

ArticleYear
Inhibition of P-glycoprotein by newer antidepressants.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection

2003